ID27507A - Komposisi farmasi yang mengandung inhibitor sistein protease untuk pencegahan dan pengobatan kerusakan jaringan otak - Google Patents

Komposisi farmasi yang mengandung inhibitor sistein protease untuk pencegahan dan pengobatan kerusakan jaringan otak

Info

Publication number
ID27507A
ID27507A IDW20002104A ID20002104A ID27507A ID 27507 A ID27507 A ID 27507A ID W20002104 A IDW20002104 A ID W20002104A ID 20002104 A ID20002104 A ID 20002104A ID 27507 A ID27507 A ID 27507A
Authority
ID
Indonesia
Prior art keywords
cyclein
protease
prevention
treatment
pharmaceutical composition
Prior art date
Application number
IDW20002104A
Other languages
English (en)
Indonesian (id)
Inventor
Mitsuyoshi Azuma
Yukuo Yoshida
Yuji Sakamoto
Jun Inoue
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Publication of ID27507A publication Critical patent/ID27507A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
IDW20002104A 1998-03-20 1999-03-17 Komposisi farmasi yang mengandung inhibitor sistein protease untuk pencegahan dan pengobatan kerusakan jaringan otak ID27507A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7228098 1998-03-20

Publications (1)

Publication Number Publication Date
ID27507A true ID27507A (id) 2001-04-12

Family

ID=13484725

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20002104A ID27507A (id) 1998-03-20 1999-03-17 Komposisi farmasi yang mengandung inhibitor sistein protease untuk pencegahan dan pengobatan kerusakan jaringan otak

Country Status (19)

Country Link
US (1) US6342531B1 (de)
EP (1) EP1064021B1 (de)
JP (1) JP2002507579A (de)
KR (1) KR20010041967A (de)
CN (1) CN1301173A (de)
AR (1) AR018784A1 (de)
AT (1) ATE275420T1 (de)
AU (1) AU2852699A (de)
BR (1) BR9908948A (de)
CA (1) CA2324566A1 (de)
DE (1) DE69919995T2 (de)
ES (1) ES2224613T3 (de)
HU (1) HUP0101428A2 (de)
ID (1) ID27507A (de)
MX (1) MXPA00009188A (de)
MY (1) MY133063A (de)
NO (1) NO20004679L (de)
PL (1) PL342970A1 (de)
WO (1) WO1999048522A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7766300A (en) * 1999-10-07 2001-05-10 Novaneuron Inc. Gene necessary for striatal function, uses thereof, and compounds for modulatingsame
JPWO2002034252A1 (ja) 2000-10-26 2004-03-04 千寿製薬株式会社 ジペプチジルアルデヒド誘導体含有医薬組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2098609A1 (en) * 1990-12-28 1992-06-29 Raymond T. Bartus Use of calpain inhibitors in the inhibition and treatment of neurodegeneration
DE69625622T2 (de) * 1995-10-25 2003-08-14 Senju Pharmaceutical Co., Ltd. Angiogenese Inhibitoren

Also Published As

Publication number Publication date
ATE275420T1 (de) 2004-09-15
AU2852699A (en) 1999-10-18
MXPA00009188A (es) 2002-04-24
EP1064021A1 (de) 2001-01-03
US6342531B1 (en) 2002-01-29
HUP0101428A2 (hu) 2001-09-28
CN1301173A (zh) 2001-06-27
ES2224613T3 (es) 2005-03-01
BR9908948A (pt) 2000-11-21
CA2324566A1 (en) 1999-09-30
JP2002507579A (ja) 2002-03-12
DE69919995D1 (de) 2004-10-14
DE69919995T2 (de) 2005-09-22
KR20010041967A (ko) 2001-05-25
NO20004679D0 (no) 2000-09-19
EP1064021B1 (de) 2004-09-08
WO1999048522A1 (en) 1999-09-30
PL342970A1 (en) 2001-07-16
NO20004679L (no) 2000-10-26
MY133063A (en) 2007-10-31
AR018784A1 (es) 2001-12-12

Similar Documents

Publication Publication Date Title
IL132388A0 (en) Kappa-opioid agonist compounds pharmaceutical compositions and method of prevention and treatment of pruritus therewith
ID21332A (id) Metode dan komposisi untuk pengobatan dan pencegahan hiperurikemia
PL333505A1 (en) Benzamido-aldehydes and their application as inhibitors of cysteinic proteases
ZA977090B (en) Pharmaceutical compositions and methods of treating compulsive disorders using NAALADase inhibitors
ATE355303T1 (de) Methoden und zusammensetzungen zur prävention und behandlung der anämie
FI961976A7 (fi) Peptidyyliyhdisteitä ja niiden terapeuttinen käyttö metalloproteinaasien inhibiittoreina
AU2002364364A8 (en) Method of treating apoptosis and compositions thereof
DE69934590D1 (de) Verbindung und verfahren zur bekämpfung und/oder behandlung der allergie
HUP0102281A3 (en) Prodrugs of dipeptidyl peptidase iv inhibitors, pharmaceutical compositions comprising thereof and their use
ID27394A (id) Kombinasi farmasi yang mengandung inhibitor cox-2 dan inhibitor inos
HUP0000210A3 (en) Heterocyclic compounds as metalloprotease inhibitors and use of them for producing pharmaceutical compisitions
HUP0102250A3 (en) Compounds of unstable dipeptidyl peptidase iv inhibitors, pharmaceutical compositions comprising thereof and their use
ATE257385T1 (de) Zusammensetzungen und verfahren zur behandlung des erhöhten augenindruckes
FI971969L (fi) Peräpukamien hoitoon tarkoitettuja koostumuksia ja käyttömenetelmä
ID17051A (id) Komposisi farmasi yang terdiri dari mirtazapine dan satu atau lebih inhibitor pengambilan kembali serotonin pilihan
EP1379232A4 (de) N-acetylcystein-zusammensetzungen und verfahren zur behandlung und prävention von arzneimitteltoxizität
ZA988017B (en) Parp inhibitors pharmaceutical compositions comprising same and methods of using same
PL316949A1 (en) Method of obtaining effective recombined inhibitors of serinic proteases and applications of such inhibitors
AU1101501A (en) Methods and compositions for treatment of keratoconus using protease inhibitors
DE60134009D1 (de) Verwendung von il-18 inhibitoren zur behandlung und/oder prävention von atherosklerose
ID18382A (id) Komposisi sediaan farmasi dan metoda pengobatan gangguan kompulsif dengan menggunakan inhibitor naaladase
HUP0302068A3 (en) Use of cox-2 inhibitors for treating or preventing immunodeficiency and pharmaceutical compositions containing them
WO2002028829A3 (en) Peptide deformylase inhibitors
ID29547A (id) Metoda dan komposisi untuk pencegahan dan pengobatan tuberkulosis
HUP0201911A3 (en) Aminobenzophenones as inhibitors of il-1betha and tnf-alpha and pharmaceutical compositions containing them